Caisse De Depot Et Placement Du Quebec Regeneron Pharmaceuticals, Inc. Transaction History
Caisse De Depot Et Placement Du Quebec
- $47 Billion
- Q4 2024
A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 310,153 shares of REGN stock, worth $213 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
310,153
Previous 194,625
59.36%
Holding current value
$213 Million
Previous $205 Million
7.98%
% of portfolio
0.47%
Previous 0.41%
Shares
30 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.38 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.85 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.32 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.25 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...